T1	Participants 194 232	patients with atrial fibrillation (AF)
T2	Participants 795 810	18,113 patients
T3	Participants 651 755	multinational (44 countries) trial of patients with nonvalvular AF and at least 1 risk factor for stroke
T4	Participants 830 855	VKA-naive and experienced
